BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
SLC12A1
,
Fatty acid metabolic process
,
Breast Cancer
,
Retina
,
Laryngoscope
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
glucosylceramide metabolic process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Myometrium
Testes
Joint synovium
Colon mucosa
Oral mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Gaucher's disease
Infestation by Sarcoptes scabiei var canis
Succinate-semialdehyde dehydrogenase deficiency
Disorder of digestive system
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
P79 protein, human
Nickel
indole
benz(a)anthracene
miglustat
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR4717
NAPEPLD
PAAF1
RPS2
MIR203A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Breast cancer response to doxorubicin and docetaxel
Normal and Mucopolysaccharidosis VII ascending aorta gene expression
H4-11-E-C3 hepatoma cells exposed to dosing of nickel, chromium and cadmium
L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown
Keratinocyte specific Fos-deletion in K5-Sos-F mouse tumor model
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for glucosylceramide metabolic process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients
Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3
Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 o…
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volun…
Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Dise…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ